Evotec advances neuroinflammation drug discovery by integrating deep neuroscience expertise, cutting-edge cell and in vivo models, and AI-driven multiomics analysis. Our end-to-end platform - from target identification to early clinical development - enables partners to de-risk programs, accelerate timelines, and deliver therapies that truly translate to human disease. With over 100 neuroscience experts and more than 200 validated CNS models, Evotec provides the scientific rigor, innovation, and flexibility needed to transform neuroinflammation research into clinical success.